BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10880018)

  • 1. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir.
    Valerie K; Hawkins W; Farnsworth J; Schmidt-Ullrich R; Lin PS; Amir C; Feden J
    Cancer Gene Ther; 2001 Jan; 8(1):3-8. PubMed ID: 11219491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion.
    Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; Valerie K
    Cancer Gene Ther; 2000 May; 7(5):778-88. PubMed ID: 10830725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus.
    Rosenberg E; Hawkins W; Holmes M; Amir C; Schmidt-Ullrich RK; Lin PS; Valerie K
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):831-6. PubMed ID: 11849808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells.
    Shewach DS; Zerbe LK; Hughes TL; Roessler BJ; Breakefield XO; Davidson BL
    Cancer Gene Ther; 1994 Jun; 1(2):107-12. PubMed ID: 7621241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS; Sabo P; Adman ET; Black ME
    Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
    Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
    Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ; Trask TW; Chen SH; Goodman JC; Woo SL; Grossman RG; Shine HD
    J Neurosci Res; 1994 Nov; 39(4):506-11. PubMed ID: 7884826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.
    Miyatake S; Martuza RL; Rabkin SD
    Cancer Gene Ther; 1997; 4(4):222-8. PubMed ID: 9253507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suicide gene therapy for glioma using HSV-tk/GCV system].
    Xu L; Ge K; Zheng Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
    Wang B; Weng J
    Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.